Covergirl Outlast Extreme Wear 3-in-1 Foundation 24 Hr Full Coverage Spf 18 Octinoxate Sunscreen Liquid Foundation Emulsion
NDC Package 22700-030-01
Package Information
Covergirl Outlast Extreme Wear 3-in-1 Foundation 24 Hr Full Coverage Spf 18 Octinoxate Sunscreen Liquid Foundation (octinoxate) emulsions is apply liberally 15 minutes before sun exposureuseawaterresistantsunscreenif swimming or sweatingreapply at least every 2 hourschildren under 6 months of age: Ask a doctorSun Protection Measures.Spending time in the sun increases your risk of skin cancer and early skin aging. This formulation utilizes a emulsion delivery system. Marketed by Noxell Corporation, this product is identified by NDC 22700-030 and is authorized under FDA application M020.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 22700 - Noxell Corporation
- 22700-030 - Covergirl Outlast Extreme Wear 3-in-1 Foundation 24 Hr Full Coverage Spf 18 Octinoxate Sunscreen Liquid Foundation
- 22700-030-01 - 1 BOTTLE in 1 CARTON / 30 mL in 1 BOTTLE
- 22700-030 - Covergirl Outlast Extreme Wear 3-in-1 Foundation 24 Hr Full Coverage Spf 18 Octinoxate Sunscreen Liquid Foundation
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 22700-030-01 identifies a specific commercial package of 1 bottle in 1 carton / 30 ml in 1 bottle of Covergirl Outlast Extreme Wear 3-in-1 Foundation 24 Hr Full Coverage Spf 18 Octinoxate Sunscreen Liquid Foundation, a human over the counter drug labeled by Noxell Corporation. This emulsion is formulated for topical use and contains octinoxate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Noxell Corporation on December 01, 2021. The current certification is valid through December 31, 2026.
How is this Noxell Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 22700003001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.